The applicant proposes basic biologic studies of the role of the RPE cell in the pathogenesis of PVR. The importance of leukocytes and their cytokine products in the development of PVR has previously been shown, as well as how these cytokines influence the phenotype and function of RPE cells. In PVR, RPE become embedded in an extracellular matrix (ECM) through which they must invade in order for PVR to develop. Three hypotheses will be tested concerning the mechanisms and post-receptor signaling pathways involved in cytokine regulation of RPE invasion of the ECM: (1) cytokines regulate adhesion to the ECM by stimulating RPE expression of integrins and ECM receptors; (2) chemotactic migration of RPE is mediated through activation of the mitogen-activated protein kinase (MAPK) pathway by stimulation of cytokine receptors, adhesion to the ECM, and convergence of other signaling pathways (PKC, focal adhesion kinase); and (3) invasion of the ECM by RPE is increased by cytokine stimulation of proteolysis and ECM phagocytosis at the sites of adhesion. To test these hypotheses the applicant will study the mechanism by which platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and tumor necrosis factor-alpha (TNF) modulate MAPK activity in human RPE cells and how these cytokines regulate RPE adhesion, migration, proteolysis, and invasion into various substrates. Finally, the applicant will test the significance of these findings by attempting to inhibit in vivo RPE invasion and experimental PVR using novel signal transduction therapy and gene therapy approaches.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY002061-24
Application #
6384285
Study Section
Visual Sciences C Study Section (VISC)
Program Officer
Dudley, Peter A
Project Start
1978-02-01
Project End
2002-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
24
Fiscal Year
2001
Total Cost
$296,447
Indirect Cost
Name
University of Southern California
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Zhu, DanHong; Sreekumar, Parameswaran G; Hinton, David R et al. (2010) Expression and regulation of enzymes in the ceramide metabolic pathway in human retinal pigment epithelial cells and their relevance to retinal degeneration. Vision Res 50:643-51
He, Shikun; Kumar, S Ram; Zhou, Peng et al. (2010) Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro. Invest Ophthalmol Vis Sci 51:543-52
Sreekumar, Parameswaran G; Ding, Yi; Ryan, Stephen J et al. (2009) Regulation of thioredoxin by ceramide in retinal pigment epithelial cells. Exp Eye Res 88:410-7
He, Shikun; Chen, Youxin; Khankan, Rima et al. (2008) Connective tissue growth factor as a mediator of intraocular fibrosis. Invest Ophthalmol Vis Sci 49:4078-88
Yaung, Jennifer; Kannan, Ram; Wawrousek, Eric F et al. (2008) Exacerbation of retinal degeneration in the absence of alpha crystallins in an in vivo model of chemically induced hypoxia. Exp Eye Res 86:355-65
Yaung, Jennifer; Jin, Manlin; Barron, Ernesto et al. (2007) alpha-Crystallin distribution in retinal pigment epithelium and effect of gene knockouts on sensitivity to oxidative stress. Mol Vis 13:566-77
Gamulescu, Maria-Andreea; Chen, Youxin; He, Shikun et al. (2006) Transforming growth factor beta2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor. Exp Eye Res 83:212-22
Sreekumar, Parameswaran G; Kannan, Ram; Yaung, Jennifer et al. (2005) Protection from oxidative stress by methionine sulfoxide reductases in RPE cells. Biochem Biophys Res Commun 334:245-53
Jin, Manlin; Yaung, Jennifer; Kannan, Ram et al. (2005) Hepatocyte growth factor protects RPE cells from apoptosis induced by glutathione depletion. Invest Ophthalmol Vis Sci 46:4311-9
Hoffmann, Stephan; He, Shikun; Jin, Manlin et al. (2005) A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion. BMC Ophthalmol 5:16

Showing the most recent 10 out of 61 publications